Loading...
XNASACB
Market cap1.48bUSD
Dec 23, Last price  
4.29USD
1D
0.47%
1Q
-25.26%
Jan 2017
-97.92%
IPO
-96.04%
Name

Aurora Cannabis Inc

Chart & Performance

D1W1MN
XNAS:ACB chart
P/E
—
P/S
7.87
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
134.58%
Rev. gr., 5y
1.74%
Revenues
270m
+15.86%
0040,8340000001,439,27118,067,00055,196,000247,939,000278,906,000245,252,000221,339,000233,290,083270,281,000
Net income
-69m
L-73.87%
1,267-177,286-145,659-43,906-322,497-315,760-393,489-399,705-9,518,369-5,723,506-12,968,00071,936,000-290,837,000-3,310,337,000-693,625,000-1,717,624,000-265,328,670-69,326,000
CFO
-69m
L-40.85%
15,114-87,256-39,037-3,084-180,910-277,979-447,844-139,794-3,324,178-6,771,479-10,506,000-81,667,000-192,245,000-337,952,000-210,577,000-109,838,000-115,821,000-68,508,000
Earnings
Feb 06, 2025

Profile

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
URL
https://www.auroramj.com/
IPO date
Sep 26, 2007
Employees
1,338
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
270,281
15.86%
233,290
5.40%
221,339
-9.75%
Cost of revenue
299,269
424,397
399,497
Unusual Expense (Income)
NOPBT
(28,988)
(191,106)
(178,158)
NOPBT Margin
Operating Taxes
(554)
(20,316)
(2,141)
Tax Rate
NOPAT
(28,434)
(170,791)
(176,017)
Net income
(69,326)
-73.87%
(265,329)
-84.55%
(1,717,624)
147.63%
Dividends
Dividend yield
Proceeds from repurchase of equity
37,926
73,187
350,188
BB yield
Debt
Debt current
57,217
147,555
33,004
Long-term debt
95,106
79,967
279,474
Deferred revenue
2,309
43,804
37,297
Other long-term liabilities
46,110
70,168
128
Net debt
28,505
(87,065)
(127,867)
Cash flow
Cash from operating activities
(68,508)
(115,821)
(109,838)
CAPEX
(16,956)
(12,132)
(32,213)
Cash from investing activities
(5,487)
(27,291)
(36,600)
Cash from financing activities
(47,923)
(56,478)
147,779
FCF
(113,612)
(263,338)
245,253
Balance
Cash
117,475
300,842
439,138
Long term investments
6,343
13,745
1,207
Excess cash
110,304
302,922
429,278
Stockholders' equity
601,870
517,137
716,862
Invested Capital
665,101
511,744
538,865
ROIC
ROCE
EV
Common stock shares outstanding
47,423
32,274
214,913
Price
Market cap
EV
EBITDA
4,083
(147,533)
(84,498)
EV/EBITDA
Interest
14,186
39,461
71,813
Interest/NOPBT